On the public citation graph
Structure, activation and dysregulation of fibroblast growth factor receptor kinases: perspectives for clinical targeting
0 signed · 232 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/cmdc.201700718openalex-snapshot
Discovery of Rogaratinib (BAY 1163877): a pan‐FGFR Inhibitor
inferredcites →https://doi.org/10.1002/ijc.21145openalex-snapshot
Constitutive activating mutation of theFGFR3b in oral squamous cell carcinomas
inferredcites →https://doi.org/10.1002/ijc.22285openalex-snapshot
Analysis of fibroblast growth factor receptor 3 G697C mutation in oral squamous cell carcinomas
inferredcites →https://doi.org/10.1002/pro.5560020109openalex-snapshot
Identification of tyrosines 154 and 307 in the extracellular domain and 653 and 766 in the intracellular domain as phosphorylation sites in the heparin‐binding fibroblast growth factor receptor tyrosine kinase (flg)
inferredcites →https://doi.org/10.1007/bf01954274openalex-snapshot
A glycine 375-to-cysteine substitution in the transmembrane domain of the fibroblast growth factor receptor-3 in a newborn with achondroplasia
inferredcites →https://doi.org/10.1007/s12010-013-0315-yopenalex-snapshot
Predicting the Impact of Deleterious Mutations in the Protein Kinase Domain of FGFR2 in the Context of Function, Structure, and Pathogenesis—a Bioinformatics Approach
inferredcites →https://doi.org/10.1016/0092-8674(91)90512-wopenalex-snapshot
Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor
inferredcites →https://doi.org/10.1016/0092-8674(94)90032-9openalex-snapshot
Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation
inferredcites →https://doi.org/10.1016/j.ccr.2009.09.028openalex-snapshot
AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance
inferredcites →https://doi.org/10.1016/j.ccr.2013.02.018openalex-snapshot
Molecular Mechanism of SSR128129E, an Extracellularly Acting, Small-Molecule, Allosteric Inhibitor of FGF Receptor Signaling
inferredcites →https://doi.org/10.1016/j.ccr.2013.02.019openalex-snapshot
Inhibition of Tumor Angiogenesis and Growth by a Small-Molecule Multi-FGF Receptor Blocker with Allosteric Properties
inferredcites →https://doi.org/10.1016/j.cell.2010.06.011openalex-snapshot
Cell Signaling by Receptor Tyrosine Kinases
inferredcites →https://doi.org/10.1016/j.celrep.2013.06.025openalex-snapshot
Cracking the Molecular Origin of Intrinsic Tyrosine Kinase Activity through Analysis of Pathogenic Gain-of-Function Mutations
inferredcites →https://doi.org/10.1016/j.chembiol.2013.05.005openalex-snapshot
Sequence Determinants of a Specific Inactive Protein Kinase Conformation
inferredcites →https://doi.org/10.1016/j.critrevonc.2017.02.018openalex-snapshot
FGFR a promising druggable target in cancer: Molecular biology and new drugs
inferredcites →https://doi.org/10.1016/j.cytogfr.2005.01.008openalex-snapshot
Structural basis for fibroblast growth factor receptor activation
inferredcites →https://doi.org/10.1016/j.cytogfr.2005.03.001openalex-snapshot
Bad bones, absent smell, selfish testes: The pleiotropic consequences of human FGF receptor mutations
inferredcites →https://doi.org/10.1016/j.gendis.2014.09.005openalex-snapshot
Fibroblast growth factor (FGF) signaling in development and skeletal diseases
inferredcites →https://doi.org/10.1016/j.jmb.2004.04.031openalex-snapshot
Towards a Resolution of the Stoichiometry of the Fibroblast Growth Factor (FGF)?FGF Receptor?Heparin Complex
inferredcites →https://doi.org/10.1016/j.jmb.2014.09.004openalex-snapshot
Structural Analysis of the Human Fibroblast Growth Factor Receptor 4 Kinase
inferredcites →https://doi.org/10.1016/j.jmb.2015.02.013openalex-snapshot
FGFR3 Unliganded Dimer Stabilization by the Juxtamembrane Domain
inferredcites →https://doi.org/10.1016/j.molcel.2006.01.022openalex-snapshot
Autophosphorylation of FGFR1 Kinase Is Mediated by a Sequential and Precisely Ordered Reaction
inferredcites →https://doi.org/10.1016/j.molcel.2007.06.028openalex-snapshot
A Molecular Brake in the Kinase Hinge Region Regulates the Activity of Receptor Tyrosine Kinases
inferredcites →https://doi.org/10.1016/j.str.2011.10.022openalex-snapshot
The Alternatively Spliced Acid Box Region Plays a Key Role in FGF Receptor Autoinhibition
inferredcites →https://doi.org/10.1016/j.str.2013.07.017openalex-snapshot
Structural Mimicry of A-Loop Tyrosine Phosphorylation by a Pathogenic FGF Receptor 3 Mutation
inferredcites →https://doi.org/10.1016/j.str.2013.08.026openalex-snapshot
Structure of FGFR3 Transmembrane Domain Dimer: Implications for Signaling and Human Pathologies
inferredcites →https://doi.org/10.1016/j.str.2014.09.019openalex-snapshot
Structural Insights into FGFR Kinase Isoform Selectivity: Diverse Binding Modes of AZD4547 and Ponatinib in Complex with FGFR1 and FGFR4
inferredcites →https://doi.org/10.1016/j.str.2017.04.015openalex-snapshot
Structural Basis of TPR-Mediated Oligomerization and Activation of Oncogenic Fusion Kinases
inferredcites →https://doi.org/10.1016/j.str.2018.01.016openalex-snapshot
Disease Variants of FGFR3 Reveal Molecular Basis for the Recognition and Additional Roles for Cdc37 in Hsp90 Chaperone System
inferredcites →https://doi.org/10.1016/j.tibs.2017.07.002openalex-snapshot
How Hsp90 and Cdc37 Lubricate Kinase Molecular Switches
inferredcites →https://doi.org/10.1016/j.tig.2004.08.007openalex-snapshot
Evolution of the Fgf and Fgfr gene families
inferredcites →https://doi.org/10.1016/s0022-3565(24)37140-xopenalex-snapshot
In Vitro Pharmacological Characterization of PD 166285, a New Nanomolar Potent and Broadly Active Protein Tyrosine Kinase Inhibitor
inferredcites →https://doi.org/10.1016/s0022-3565(24)37619-0openalex-snapshot
In Vitro Biological Characterization and Antiangiogenic Effects of PD 166866, a Selective Inhibitor of the FGF-1 Receptor Tyrosine Kinase
inferredcites →https://doi.org/10.1016/s0092-8674(00)80051-3openalex-snapshot
Structural Basis for FGF Receptor Dimerization and Activation
inferredcites →https://doi.org/10.1016/s0092-8674(00)80131-2openalex-snapshot
Structure of the FGF Receptor Tyrosine Kinase Domain Reveals a Novel Autoinhibitory Mechanism
inferredcites →https://doi.org/10.1016/s0092-8674(00)80252-4openalex-snapshot
A Lipid-Anchored Grb2-Binding Protein That Links FGF-Receptor Activation to the Ras/MAPK Signaling Pathway
inferredcites →https://doi.org/10.1016/s0092-8674(00)80851-xopenalex-snapshot
Crystal Structures of Two FGF-FGFR Complexes Reveal the Determinants of Ligand-Receptor Specificity
inferredcites →https://doi.org/10.1016/s0959-440x(00)00258-xopenalex-snapshot
Role of heparan sulfate in fibroblast growth factor signalling: a structural view
inferredcites →https://doi.org/10.1016/s0959-8049(16)32704-6openalex-snapshot
First-in-human study of BLU-554, a potent, highly-selective FGFR4 inhibitor designed for hepatocellular carcinoma (HCC) with FGFR4 pathway activation
inferredcites →https://doi.org/10.1016/s1097-2765(00)00073-3openalex-snapshot
Crystal Structure of a Ternary FGF-FGFR-Heparin Complex Reveals a Dual Role for Heparin in FGFR Binding and Dimerization
inferredcites →https://doi.org/10.1016/s1097-2765(05)00087-0openalex-snapshot
Structural Basis of SNT PTB Domain Interactions with Distinct Neurotrophic Receptors
inferredcites →https://doi.org/10.1021/acs.jmedchem.7b00360openalex-snapshot
Discovery of the Irreversible Covalent FGFR Inhibitor 8-(3-(4-Acryloylpiperazin-1-yl)propyl)-6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one (PRN1371) for the Treatment of Solid Tumors
inferredcites →https://doi.org/10.1021/bi200986fopenalex-snapshot
The Physical Basis of FGFR3 Response to fgf1 and fgf2
inferredcites →https://doi.org/10.1021/jm2006222openalex-snapshot
Discovery of 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), A Potent and Selective Inhibitor of the Fibroblast Growth Factor Receptor Family of Receptor Tyrosine Kinase
inferredcites →https://doi.org/10.1021/jm501603hopenalex-snapshot
Conformational Analysis of the DFG-Out Kinase Motif and Biochemical Profiling of Structurally Validated Type II Inhibitors
inferredcites →https://doi.org/10.1038/35039551openalex-snapshot
Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin
inferredcites →https://doi.org/10.1038/35048589openalex-snapshot
Attenuation of FGF signalling in mouse β-cells leads to diabetes
inferredcites →https://doi.org/10.1038/358678a0openalex-snapshot
Point mutation of an FGF receptor abolishes phosphatidylinositol turnover and Ca2+ flux but not mitogenesis
inferredcites →https://doi.org/10.1038/358681a0openalex-snapshot
Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis
inferredcites →https://doi.org/10.1038/nature05610openalex-snapshot
Patterns of somatic mutation in human cancer genomes
inferredcites →https://doi.org/10.1038/nature25010openalex-snapshot
Structures of β-klotho reveal a ‘zip code’-like mechanism for endocrine FGF signalling
inferredcites →https://doi.org/10.1038/nature25451openalex-snapshot
α-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling
inferredcites →https://doi.org/10.1038/nbt.1990openalex-snapshot
Comprehensive analysis of kinase inhibitor selectivity
inferredcites →https://doi.org/10.1038/ncomms10262openalex-snapshot
Mechanism of FGF receptor dimerization and activation
inferredcites →https://doi.org/10.1038/ncomms8877openalex-snapshot
Structural and dynamic insights into the energetics of activation loop rearrangement in FGFR1 kinase
inferredcites →https://doi.org/10.1038/ng0795-357openalex-snapshot
A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia
inferredcites →https://doi.org/10.1038/ng1295-462openalex-snapshot
Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans
inferredcites →https://doi.org/10.1038/nrc.2017.8openalex-snapshot
Advances and challenges in targeting FGFR signalling in cancer
inferredcites →https://doi.org/10.1038/nrc2780openalex-snapshot
Fibroblast growth factor signalling: from development to cancer
inferredcites →https://doi.org/10.1038/nrd2792openalex-snapshot
The FGF family: biology, pathophysiology and therapy
inferredcites →https://doi.org/10.1038/nrendo.2009.196openalex-snapshot
The FGF23–Klotho axis: endocrine regulation of phosphate homeostasis
inferredcites →https://doi.org/10.1038/nrm3528openalex-snapshot
Exploring mechanisms of FGF signalling through the lens of structural biology
inferredcites →https://doi.org/10.1038/onc.2012.319openalex-snapshot
Tumour cell responses to new fibroblast growth factor receptor tyrosine kinase inhibitors and identification of a gatekeeper mutation in FGFR3 as a mechanism of acquired resistance
inferredcites →https://doi.org/10.1038/onc.2014.161openalex-snapshot
Ligand-associated ERBB2/3 activation confers acquired resistance to FGFR inhibition in FGFR3-dependent cancer cells
inferredcites →https://doi.org/10.1038/sj.bjc.6606016openalex-snapshot
Small molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivo
inferredcites →https://doi.org/10.1073/pnas.0307287101openalex-snapshot
Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity
inferredcites →https://doi.org/10.1073/pnas.0607656103openalex-snapshot
Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism
inferredcites →https://doi.org/10.1073/pnas.0807988105openalex-snapshot
A helix scaffold for the assembly of active protein kinases
inferredcites →https://doi.org/10.1073/pnas.0914157107openalex-snapshot
Asymmetric receptor contact is required for tyrosine autophosphorylation of fibroblast growth factor receptor in living cells
inferredcites →https://doi.org/10.1073/pnas.1403438111openalex-snapshot
Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors
inferredcites →https://doi.org/10.1073/pnas.161259898openalex-snapshot
Critical role for the docking-protein FRS2α in FGF receptor-mediated signal transduction pathways
inferredcites →https://doi.org/10.1073/pnas.97.1.49openalex-snapshot
Structural interactions of fibroblast growth factor receptor with its ligands
inferredcites →https://doi.org/10.1074/jbc.270.17.10222openalex-snapshot
Ligand-specific Structural Domains in the Fibroblast Growth Factor Receptor
inferredcites →https://doi.org/10.1074/jbc.270.17.10231openalex-snapshot
Alternately Spliced NH2-terminal Immunoglobulin-like Loop I in the Ectodomain of the Fibroblast Growth Factor (FGF) Receptor 1 Lowers Affinity for both Heparin and FGF-1
inferredcites →https://doi.org/10.1074/jbc.m102777200openalex-snapshot
Interaction of Fibroblast Growth Factor Receptor 3 and the Adapter Protein SH2-B
inferredcites →https://doi.org/10.1074/jbc.m111.275891openalex-snapshot
Plasticity in Interactions of Fibroblast Growth Factor 1 (FGF1) N Terminus with FGF Receptors Underlies Promiscuity of FGF1
inferredcites →https://doi.org/10.1074/jbc.m115.681395openalex-snapshot
Unliganded Fibroblast Growth Factor Receptor 1 Forms Density-independent Dimers
inferredcites →https://doi.org/10.1083/jcb.201711047openalex-snapshot
Visualization of ligand-induced transmembrane signaling in the full-length human insulin receptor
inferredcites →https://doi.org/10.1091/mbc.12.4.931openalex-snapshot
Identification of Tyrosine Residues in Constitutively Activated Fibroblast Growth Factor Receptor 3 Involved in Mitogenesis, Stat Activation, and Phosphatidylinositol 3-Kinase Activation
inferredcites →https://doi.org/10.1093/annonc/mdy149openalex-snapshot
Efficacy of TAS-120, an irreversible fibroblast growth factor receptor (FGFR) inhibitor, in cholangiocarcinoma patients with FGFR pathway alterations who were previously treated with chemotherapy and other FGFR inhibitors
inferredcites →https://doi.org/10.1093/emboj/17.20.5896openalex-snapshot
Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain
inferredcites →https://doi.org/10.1093/hmg/4.11.2175openalex-snapshot
Another mutation that results in the substitution of an unpaired cysteine residue in the extracellular domain of FGFR3 in thanatophoric dysplasia type I
inferredcites →https://doi.org/10.1093/hmg/ddi127openalex-snapshot
Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans
inferredcites →https://doi.org/10.1093/hmg/dds486openalex-snapshot
Oncogenic FGFR3 gene fusions in bladder cancer
inferredcites →https://doi.org/10.1093/protein/3.4.245openalex-snapshot
A sequence motif in the transmembrane region of growth factor receptors with tyrosine kinase activity mediates dimerization
inferredcites →https://doi.org/10.1101/gad.1365406openalex-snapshot
Structural basis by which alternative splicing modulates the organizer activity of FGF8 in the brain
inferredcites →https://doi.org/10.1126/sciadv.1600663openalex-snapshot
A dynamic hydrophobic core orchestrates allostery in protein kinases
inferredcites →https://doi.org/10.1126/science.1075762openalex-snapshot
The Protein Kinase Complement of the Human Genome
inferredcites →https://doi.org/10.1126/science.1220834openalex-snapshot
Transforming Fusions of FGFR and TACC Genes in Human Glioblastoma
inferredcites →https://doi.org/10.1126/science.1646484openalex-snapshot
Requirement of Heparan Sulfate for bFGF-Mediated Fibroblast Growth and Myoblast Differentiation
inferredcites →https://doi.org/10.1126/science.1702556openalex-snapshot
Three-Dimensional Structures of Acidic and Basic Fibroblast Growth Factors
inferredcites →https://doi.org/10.1126/scisignal.2000021openalex-snapshot
The Precise Sequence of FGF Receptor Autophosphorylation Is Kinetically Driven and Is Disrupted by Oncogenic Mutations
inferredcites →https://doi.org/10.1128/mcb.00943-14openalex-snapshot
Kinase Regulation by Hydrophobic Spine Assembly in Cancer
inferredcites →https://doi.org/10.1128/mcb.13.7.3907openalex-snapshot
Control of Fibroblast Growth Factor Receptor Kinase Signal Transduction by Heterodimerization of Combinatorial Splice Variants
inferredcites →https://doi.org/10.1128/mcb.16.3.977openalex-snapshot
Identification of Six Novel Autophosphorylation Sites on Fibroblast Growth Factor Receptor 1 and Elucidation of Their Importance in Receptor Activation and Signal Transduction
inferredcites →https://doi.org/10.1158/0008-5472.can-07-6307openalex-snapshot
BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy
inferredcites →https://doi.org/10.1158/0008-5472.can-10-2700openalex-snapshot
E-3810 Is a Potent Dual Inhibitor of VEGFR and FGFR that Exerts Antitumor Activity in Multiple Preclinical Models
inferredcites →https://doi.org/10.1158/0008-5472.can-11-3034openalex-snapshot
AZD4547: An Orally Bioavailable, Potent, and Selective Inhibitor of the Fibroblast Growth Factor Receptor Tyrosine Kinase Family
inferredcites →https://doi.org/10.1158/0008-5472.can-16-0180openalex-snapshot
Preclinical Efficacy of the Auristatin-Based Antibody–Drug Conjugate BAY 1187982 for the Treatment of FGFR2-Positive Solid Tumors
inferredcites →https://doi.org/10.1158/0008-5472.can-17-1865openalex-snapshot
H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1158/1078-0432.ccr-12-2694openalex-snapshot
Translating the Therapeutic Potential of AZD4547 in FGFR1 -Amplified Non–Small Cell Lung Cancer through the Use of Patient-Derived Tumor Xenograft Models
inferredcites →https://doi.org/10.1158/1078-0432.ccr-12-3898openalex-snapshot
FGFR2 Gene Amplification in Gastric Cancer Predicts Sensitivity to the Selective FGFR Inhibitor AZD4547
inferredcites →https://doi.org/10.1158/1078-0432.ccr-14-2329openalex-snapshot
Targeting FGFR Signaling in Cancer
inferredcites →https://doi.org/10.1158/1535-7163.mct-11-0306openalex-snapshot
A Novel, Selective Inhibitor of Fibroblast Growth Factor Receptors That Shows a Potent Broad Spectrum of Antitumor Activity in Several Tumor Xenograft Models
inferredcites →https://doi.org/10.1158/1535-7163.mct-14-0248openalex-snapshot
The Fibroblast Growth Factor Receptor Genetic Status as a Potential Predictor of the Sensitivity to CH5183284/Debio 1347, a Novel Selective FGFR Inhibitor
inferredcites →https://doi.org/10.1158/1535-7163.mct-16-0589openalex-snapshot
Discovery and Pharmacological Characterization of JNJ-42756493 (Erdafitinib), a Functionally Selective Small-Molecule FGFR Family Inhibitor
inferredcites →https://doi.org/10.1158/1538-7445.am2013-lb-145openalex-snapshot
Abstract LB-145: Results of a phase I study of AZD4547, an inhibitor of fibroblast growth factor receptor (FGFR), in patients with advanced solid tumors .
inferredcites →https://doi.org/10.1158/1538-7445.am2014-4766openalex-snapshot
Abstract 4766: Pharmacodynamic and stratification biomarker for the anti-FGFR2 antibody (BAY1179470) and the FGFR2-ADC
inferredcites →https://doi.org/10.1158/1538-7445.am2015-771openalex-snapshot
Abstract 771: Preclinical characterization of the selective FGFR inhibitor INCB054828
inferredcites →https://doi.org/10.1158/1538-7445.am2017-2098openalex-snapshot
Abstract 2098: NVP-FGF401, a first-in-class highly selective and potent FGFR4 inhibitor for the treatment of HCC
inferredcites →https://doi.org/10.1158/2159-8290.cd-13-0050openalex-snapshot
Identification of Targetable FGFR Gene Fusions in Diverse Cancers
inferredcites →https://doi.org/10.1158/2159-8290.cd-14-1029openalex-snapshot
First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway
inferredcites →https://doi.org/10.1182/blood-2004-10-3913openalex-snapshot
CHIR-258, a novel, multitargeted tyrosine kinase inhibitor for the potential treatment of t(4;14) multiple myeloma
inferredcites →https://doi.org/10.1182/blood.v120.21.4029.4029openalex-snapshot
A Phase I Study of the Safety and Pharmacokinetics of Escalating Doses of MFGR1877S, a Fibroblast Growth Factor Receptor 3 (FGFR3) Antibody, in Patients with Relapsed or Refractory t(4;14)-Positive Multiple Myeloma
inferredcites →https://doi.org/10.1200/jco.2014.32.15_suppl.e15074openalex-snapshot
FPA144, a humanized monoclonal antibody for both FGFR2-amplified and nonamplified, FGFR2b-overexpressing gastric cancer patients.
inferredcites →https://doi.org/10.1242/dev.037689openalex-snapshot
FGF signalling: diverse roles during early vertebrate embryogenesis
inferredcites →https://doi.org/10.1371/journal.pcbi.1005360openalex-snapshot
Effects of FGFR2 kinase activation loop dynamics on catalytic activity
inferredcites →https://doi.org/10.1371/journal.pone.0066923openalex-snapshot
Peripheral Reduction of FGFR4 with Antisense Oligonucleotides Increases Metabolic Rate and Lowers Adiposity in Diet-Induced Obese Mice
inferredcites →https://doi.org/10.1371/journal.pone.0162594openalex-snapshot
Preclinical Activity of ARQ 087, a Novel Inhibitor Targeting FGFR Dysregulation
inferredcites →https://doi.org/10.18632/oncotarget.14109openalex-snapshot
Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application
inferredcites →https://doi.org/10.18632/oncotarget.8132openalex-snapshot
Landscape of activating cancer mutations in FGFR kinases and their differential responses to inhibitors in clinical use
inferredcites →https://doi.org/10.18632/oncotarget.9515openalex-snapshot
Inhibition of FGF/FGFR autocrine signaling in mesothelioma with the FGF ligand trap, FP-1039/GSK3052230
inferredcites →https://doi.org/10.20892/j.issn.2095-3941.2015.0102openalex-snapshot
Characterization of FGFR signaling pathway as therapeutic targets for sarcoma patients
inferredcites →https://doi.org/10.3892/ijmm.2016.2620openalex-snapshot
FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review)
inferredcites →https://doi.org/10.4161/cam.4.2.11191openalex-snapshot
Transmembrane helix-helix interactions involved in ErbB receptor signaling
inferredcites →https://doi.org/10.7554/elife.21137openalex-snapshot
Elucidation of a four-site allosteric network in fibroblast growth factor receptor tyrosine kinases
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4830431openalex-extracted
The Caenorhabditis Elegans Protein Soc-3 Permits an Alternative Mode of Signal Transduction by the Egl-15 Fgf Receptor
inferred← citeshttps://doi.org/10.1002/ange.202101328openalex-snapshot
Discovery of a Potent Degrader for Fibroblast Growth Factor Receptor 1/2
inferred← citeshttps://doi.org/10.1002/anie.202101328openalex-snapshot
Discovery of a Potent Degrader for Fibroblast Growth Factor Receptor 1/2
inferred← citeshttps://doi.org/10.1002/cbdv.202501396openalex-snapshot
Medicinal Chemistry Perspective of 1,8‐Naphthyridines as Anticancer Agents
inferred← citeshttps://doi.org/10.1002/ijc.33352openalex-snapshot
Epithelial‐to‐mesenchymal transition in oral squamous cell carcinoma: Challenges and opportunities
inferred← citeshttps://doi.org/10.1002/jcc.26122openalex-snapshot
Role of the N‐Terminal Transmembrane Helix Contacts in the Activation of FGFR3
inferred← citeshttps://doi.org/10.1002/wdev.384openalex-snapshot
Integrating levels of bone growth control: From stem cells to body proportions
inferred← citeshttps://doi.org/10.1007/978-3-031-68827-0_21openalex-snapshot
Electrical Forces Improve Memory in Old Age
inferred← citeshttps://doi.org/10.1007/978-3-031-70835-0_8openalex-snapshot
FGF Signaling: A Key Pathway During Skeletal Development
inferred← citeshttps://doi.org/10.1007/978-3-031-93894-8_7openalex-snapshot
Receptor Tyrosine Kinase Signaling and Mitochondrial Dynamics in Cancer
inferred← citeshttps://doi.org/10.1007/s00018-023-04768-xopenalex-snapshot
Receptor clustering by a precise set of extracellular galectins initiates FGFR signaling
inferred← citeshttps://doi.org/10.1007/s12020-022-03074-zopenalex-snapshot
FGF/FGFR signaling in adrenocortical development and tumorigenesis: novel potential therapeutic targets in adrenocortical carcinoma
inferred← citeshttps://doi.org/10.1016/b978-0-12-820472-6.00135-3openalex-snapshot
Receptor Tyrosine Kinases
inferred← citeshttps://doi.org/10.1016/b978-0-443-18677-6.00012-9openalex-snapshot
Receptor tyrosine kinases (RTKs)
inferred← citeshttps://doi.org/10.1016/j.acuro.2025.501719openalex-snapshot
Implicaciones biológicas y terapéuticas de las alteraciones del receptor del factor de crecimiento de fibroblastos (FGFR) en el cáncer urotelial: una revisión sistemática desde la enfermedad no musculoinvasiva a la metastásica
inferred← citeshttps://doi.org/10.1016/j.acuroe.2025.501719openalex-snapshot
Biological and therapeutic implications of FGFR alterations in urothelial cancer: A systematic review from non-muscle-invasive to metastatic disease
inferred← citeshttps://doi.org/10.1016/j.bbrc.2020.02.123openalex-snapshot
Systemic Klotho therapy protects against insulitis and enhances beta-cell mass in NOD mice
inferred← citeshttps://doi.org/10.1016/j.bcp.2020.114084openalex-snapshot
Receptor tyrosine kinases and heparan sulfate proteoglycans: Interplay providing anticancer targeting strategies and new therapeutic opportunities
inferred← citeshttps://doi.org/10.1016/j.bcp.2023.115853openalex-snapshot
FGF2 drives osteosarcoma metastasis through activating FGFR1-4 receptor pathway-mediated ICAM-1 expression
inferred← citeshttps://doi.org/10.1016/j.carres.2026.109925openalex-snapshot
In vitro and in silico studies on anticancer activities of alginate oligosaccharide in Epstein-Barr virus-positive nasopharyngeal carcinoma
inferred← citeshttps://doi.org/10.1016/j.celrep.2020.02.074openalex-snapshot
Mechanical Stress Regulates Epithelial Tissue Integrity and Stiffness through the FGFR/Erk2 Signaling Pathway during Embryogenesis
inferred← citeshttps://doi.org/10.1016/j.compbiomed.2025.110761openalex-snapshot
Fibroblast growth factor 21 responds to taurocholic acid sodium-induced acute pancreatic injury
inferred← citeshttps://doi.org/10.1016/j.cytogfr.2021.03.004openalex-snapshot
Galectins as modulators of receptor tyrosine kinases signaling in health and disease
inferred← citeshttps://doi.org/10.1016/j.cytogfr.2024.04.001openalex-snapshot
Glycosylation of FGF/FGFR: An underrated sweet code regulating cellular signaling programs
inferred← citeshttps://doi.org/10.1016/j.ejmech.2024.116780openalex-snapshot
Synthesis and identification of a selective FGFR2 degrader with potent antiproliferative effects in gastric cancer
inferred← citeshttps://doi.org/10.1016/j.jbc.2022.102247openalex-snapshot
Structural features of the protein kinase domain and targeted binding by small-molecule inhibitors
inferred← citeshttps://doi.org/10.1016/j.jbc.2022.102832openalex-snapshot
Measurement of FGFR3 signaling at the cell membrane via total internal reflection fluorescence microscopy to compare the activation of FGFR3 mutants
inferred← citeshttps://doi.org/10.1016/j.str.2018.01.016openalex-snapshot
Disease Variants of FGFR3 Reveal Molecular Basis for the Recognition and Additional Roles for Cdc37 in Hsp90 Chaperone System
inferred← citeshttps://doi.org/10.1016/j.tranon.2020.100944openalex-snapshot
Integration of whole-exome and anchored PCR-based next generation sequencing significantly increases detection of actionable alterations in precision oncology
inferred← citeshttps://doi.org/10.1016/j.ydbio.2024.08.014openalex-snapshot
The Caenorhabditis elegans protein SOC-3 permits an alternative mode of signal transduction by the EGL-15 FGF receptor
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.4c01531openalex-snapshot
Discovery of TYRA-300: First Oral Selective FGFR3 Inhibitor for the Treatment of Urothelial Cancers and Achondroplasia
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.6c00514openalex-snapshot
Structure-Based Design of a Novel Covalent 4-(1-Methylindol-3-yl)pyrimidin-2-amine Series Targeting FGFR2 Resistance Mutations
inferred← citeshttps://doi.org/10.1021/jacs.5c01712openalex-snapshot
Residue-Selective Inhibitors Discovery via Covalent DNA-Encoded Chemical Libraries with Diverse Warheads
inferred← citeshttps://doi.org/10.1038/s41392-020-00222-7openalex-snapshot
FGF/FGFR signaling in health and disease
inferred← citeshttps://doi.org/10.1038/s41392-022-01200-xopenalex-snapshot
Signaling pathways and targeted therapies in lung squamous cell carcinoma: mechanisms and clinical trials
inferred← citeshttps://doi.org/10.1038/s41467-024-45247-6openalex-snapshot
The molecular interaction pattern of lenvatinib enables inhibition of wild-type or kinase-mutated FGFR2-driven cholangiocarcinoma
inferred← citeshttps://doi.org/10.1038/s41568-020-0256-zopenalex-snapshot
The duality of human oncoproteins: drivers of cancer and congenital disorders
inferred← citeshttps://doi.org/10.1038/s41574-019-0304-5openalex-snapshot
Role of thyroid hormones in craniofacial development
inferred← citeshttps://doi.org/10.1038/s41598-021-01029-4openalex-snapshot
A designed fusion tag for soluble expression and selective separation of extracellular domains of fibroblast growth factor receptors
inferred← citeshttps://doi.org/10.1038/s41598-024-52991-8openalex-snapshot
Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies
inferred← citeshttps://doi.org/10.1038/s41598-024-60031-8openalex-snapshot
RAPID resistance to BET inhibitors is mediated by FGFR1 in glioblastoma
inferred← citeshttps://doi.org/10.1038/s41598-025-86194-6openalex-snapshot
Cell-free expression and SMA copolymer encapsulation of a functional receptor tyrosine kinase disease variant, FGFR3-TACC3
inferred← citeshttps://doi.org/10.1038/s42004-021-00623-xopenalex-snapshot
Structural insights into the potency and selectivity of covalent pan-FGFR inhibitors
inferred← citeshttps://doi.org/10.1042/bst20221124openalex-snapshot
The discovery, function, and regulation of epithelial splicing regulatory proteins (ESRP) 1 and 2
inferred← citeshttps://doi.org/10.1053/j.gastro.2020.01.051openalex-snapshot
Therapeutic Landscape for NAFLD in 2020
inferred← citeshttps://doi.org/10.1071/rd21025openalex-snapshot
The immunoexpression patterns of fibroblast growth factors in the pregnant and postpartum rat ovary
inferred← citeshttps://doi.org/10.1080/07391102.2023.2191721openalex-snapshot
The FGF/FGFR signalling mediated anti-cancer drug resistance and therapeutic intervention
inferred← citeshttps://doi.org/10.1080/07391102.2023.2217924openalex-snapshot
Decoupling the dynamic mechanism revealed by FGFR2 mutation-induced population shift
inferred← citeshttps://doi.org/10.1080/13543784.2021.1900821openalex-snapshot
Targeting FGFR in intrahepatic cholangiocarcinoma [iCCA]: leading the way for precision medicine in biliary tract cancer [BTC]?
inferred← citeshttps://doi.org/10.1080/13543784.2022.2017879openalex-snapshot
FGFR4 inhibitors for the treatment of hepatocellular carcinoma: a synopsis of therapeutic potential
inferred← citeshttps://doi.org/10.1080/14656566.2025.2605200openalex-snapshot
Recent advances in the treatment of FGFR-altered cholangiocarcinoma
inferred← citeshttps://doi.org/10.1080/17512433.2021.1947246openalex-snapshot
Selective FGFR/FGF pathway inhibitors: inhibition strategies, clinical activities, resistance mutations, and future directions
inferred← citeshttps://doi.org/10.1093/gbe/evae015openalex-snapshot
Exploring FGFR3 Mutations in the Male Germline: Implications for Clonal Germline Expansions and Paternal Age-Related Dysplasias
inferred← citeshttps://doi.org/10.1093/jnen/nlae040openalex-snapshot
Exploring a distinct FGFR2::DLG5 rearrangement in a low-grade neuroepithelial tumor: A case report and mini-review of protein fusions in brain tumors
inferred← citeshttps://doi.org/10.1093/jxb/eraa192openalex-snapshot
Interactions between the N- and C-termini of the mechanosensitive ion channel At MSL10 are consistent with a three-step mechanism for activation
inferred← citeshttps://doi.org/10.1096/fj.202600529rropenalex-snapshot
Blockade of FGFR 1 Trafficking to the Cell Surface Results in the Partial Mistargeting of the Receptor to Peroxisomes
inferred← citeshttps://doi.org/10.1098/rsob.210373openalex-snapshot
Fibroblast growth factor receptor signalling dysregulation and targeting in breast cancer
inferred← citeshttps://doi.org/10.1101/2022.07.31.502216openalex-snapshot
Activating mutations in FGFR3 are associated with clonal expansion events and high de novo rates in the male germline
inferred← citeshttps://doi.org/10.1101/2025.10.12.681903openalex-snapshot
Direct cell reprogramming by a designed agonist inducing HER2-FGFR proximity
inferred← citeshttps://doi.org/10.1101/726521openalex-snapshot
Interactions between the N- and C- termini of mechanosensitive ion channel At MSL10 are consistent with a three-step mechanism for activation
inferred← citeshttps://doi.org/10.1111/cpr.13009openalex-snapshot
Inhibition of FGF‐FGFR and VEGF‐VEGFR signalling in cancer treatment
inferred← citeshttps://doi.org/10.1111/cpr.13732openalex-snapshot
Flavonoid chrysin activates both TrkB and FGFR1 receptors while upregulates their endogenous ligands such as brain derived neurotrophic factor to promote human neurogenesis
inferred← citeshttps://doi.org/10.1155/2021/9955456openalex-snapshot
2b or Not 2b: How Opposing FGF Receptor Splice Variants Are Blocking Progress in Precision Oncology
inferred← citeshttps://doi.org/10.1158/2159-8290.cd-19-1156openalex-snapshot
Precision Oncology for Hepatocellular Cancer: Slivering the Liver by FGF19–FGFR4–KLB Pathway Inhibition
inferred← citeshttps://doi.org/10.1172/jci.insight.168796openalex-snapshot
Hypochondroplasia gain-of-function mutation in FGFR3 causes defective bone mineralization in mice
inferred← citeshttps://doi.org/10.1186/s12931-019-1244-2openalex-snapshot
Protein tyrosine kinase 2: a novel therapeutic target to overcome acquired EGFR-TKI resistance in non-small cell lung cancer
inferred← citeshttps://doi.org/10.1186/s12964-024-01661-3openalex-snapshot
The diverse dependence of galectin-1 and -8 on multivalency for the modulation of FGFR1 endocytosis
inferred← citeshttps://doi.org/10.1186/s13018-023-04119-3openalex-snapshot
Effects and action mechanisms of individual cytokines contained in PRP on osteoarthritis
inferred← citeshttps://doi.org/10.1200/po.22.00435openalex-snapshot
Use of Erdafitinib in FGFR3-Mutated Recurrent Respiratory Papillomatosis
inferred← citeshttps://doi.org/10.1242/dmm.052123openalex-snapshot
Generation of human induced pluripotent stem cell lines from patients with FGFR2-linked syndromic craniosynostosis
inferred← citeshttps://doi.org/10.1297/cpe.2022-0060openalex-snapshot
A novel missense variant of FGFR1 in a Japanese girl with Kallmann syndrome and holoprosencephaly
inferred← citeshttps://doi.org/10.14201/gredos.157699openalex-snapshot
Búsqueda de biomarcadores pronósticos y terapéuticos en el carcinoma pulmonar de células escamosas. Correlación clínico-patológica
inferred← citeshttps://doi.org/10.20517/2394-5079.2023.68openalex-snapshot
Targeted mutation-based therapy for intrahepatic cholangiocarcinoma
inferred← citeshttps://doi.org/10.2139/ssrn.4080536openalex-snapshot
Quantitation of Fgfr3 Signaling Via Grb2 Recruitment on Micropatterned Surfaces
inferred← citeshttps://doi.org/10.2147/ott.s282718openalex-snapshot
Targeting FGFR2 Positive Gastroesophageal Cancer: Current and Clinical Developments
inferred← citeshttps://doi.org/10.2147/ott.s297643openalex-snapshot
Promising Molecular Targets for the Targeted Therapy of Biliary Tract Cancers: An Overview
inferred← citeshttps://doi.org/10.32604/or.2024.047042openalex-snapshot
A review on potential heterocycles for the treatment of glioblastoma targeting receptor tyrosine kinases
inferred← citeshttps://doi.org/10.3389/fcell.2023.1112890openalex-snapshot
FGF signaling in cranial suture development and related diseases
inferred← citeshttps://doi.org/10.3389/fchem.2021.764200openalex-snapshot
Synthesis of Novel Suramin Analogs With Anti-Proliferative Activity via FGF1 and FGFRD2 Blockade
inferred← citeshttps://doi.org/10.3389/fimmu.2024.1390453openalex-snapshot
Fibroblast growth factor signaling in macrophage polarization: impact on health and diseases
inferred← citeshttps://doi.org/10.3389/fimmu.2026.1953431openalex-snapshot
FGFR signaling and apoptotic regulation in cancer: links to immune evasion, therapeutic resistance, and treatment re-engagement
inferred← citeshttps://doi.org/10.3389/fonc.2022.953013openalex-snapshot
Comparative kinase and cancer cell panel profiling of kinase inhibitors approved for clinical use from 2018 to 2020
inferred← citeshttps://doi.org/10.3389/fonc.2024.1406951openalex-snapshot
Fibroblast growth factor receptor signaling in estrogen receptor-positive breast cancer: mechanisms and role in endocrine resistance
inferred← citeshttps://doi.org/10.3389/fonc.2026.1847493openalex-snapshot
Research progress of small molecule targeted drugs for non-small cell lung cancer
inferred← citeshttps://doi.org/10.3389/fphys.2021.632260openalex-snapshot
An Overview of FGF-23 as a Novel Candidate Biomarker of Cardiovascular Risk
inferred← citeshttps://doi.org/10.3390/biom11081088openalex-snapshot
FGF1 Fusions with the Fc Fragment of IgG1 for the Assembly of GFPpolygons-Mediated Multivalent Complexes Recognizing FGFRs
inferred← citeshttps://doi.org/10.3390/biomedicines12051117openalex-snapshot
Clinical Developments and Challenges in Treating FGFR2-Driven Gastric Cancer
inferred← citeshttps://doi.org/10.3390/cancers12123825openalex-snapshot
Role of Fibroblast Growth Factors Receptors (FGFRs) in Brain Tumors, Focus on Astrocytoma and Glioblastoma
inferred← citeshttps://doi.org/10.3390/cancers18010089openalex-snapshot
FGFR Aberrations in Solid Tumors: Mechanistic Insights and Clinical Translation of Targeted Therapies
inferred← citeshttps://doi.org/10.3390/cells10082148openalex-snapshot
Functional Roles of FGF Signaling in Early Development of Vertebrate Embryos
inferred← citeshttps://doi.org/10.3390/cells8060540openalex-snapshot
Fibroblast Growth Factor Receptor Signaling in Skin Cancers
inferred← citeshttps://doi.org/10.3390/cells8060614openalex-snapshot
Fibroblast Growth Factor Receptors (FGFRs): Structures and Small Molecule Inhibitors
inferred← citeshttps://doi.org/10.3390/cimb46110783openalex-snapshot
Pharmacological and Biological Targeting of FGFR1 in Cancer
inferred← citeshttps://doi.org/10.3390/curroncol31080321openalex-snapshot
Deciphering the FGFR2 Code: Innovative Targets in Gastric Cancer Therapy
inferred← citeshttps://doi.org/10.3390/genes15060798openalex-snapshot
Signaling Pathways Governing Cardiomyocyte Differentiation
inferred← citeshttps://doi.org/10.3390/ijms20051028openalex-snapshot
Cell Metabolism Control Through O-GlcNAcylation of STAT5: A Full or Empty Fuel Tank Makes a Big Difference for Cancer Cell Growth and Survival
inferred← citeshttps://doi.org/10.3390/ijms21218021openalex-snapshot
Trametinib Induces the Stabilization of a Dual GNAQ p.Gly48Leu- and FGFR4 p.Cys172Gly-Mutated Uveal Melanoma. The Role of Molecular Modelling in Personalized Oncology
inferred← citeshttps://doi.org/10.3390/ijms22020747openalex-snapshot
Novel Tyrosine Kinase Targets in Urothelial Carcinoma
inferred← citeshttps://doi.org/10.3390/proteomes14010008openalex-snapshot
Proteome-Wide Analysis of Functional Phosphosites in the FGFR Family of Proteins: Insights from Large-Scale Phosphoproteomic Analysis
inferred← citeshttps://doi.org/10.3390/vaccines10091490openalex-snapshot
Molecular Crosstalk between the Immunological Mechanism of the Tumor Microenvironment and Epithelial–Mesenchymal Transition in Oral Cancer
inferred← citeshttps://doi.org/10.4103/abr.abr_170_23openalex-snapshot
The Application of Artificial Intelligence and Drug Repositioning for the Identification of Fibroblast Growth Factor Receptor Inhibitors: A Review
inferred← citeshttps://doi.org/10.4103/crst.crst_176_23openalex-snapshot
Erdafitinib for tumors with FGFR3 mutation: A promising targeted therapy
inferred← citeshttps://doi.org/10.4155/fmc-2022-0194openalex-snapshot
Targeting FGFRs for Tumor Therapy: Current Status and Novel Strategies
inferred← citeshttps://doi.org/10.5772/intechopen.1015716openalex-snapshot
Perspective Chapter: FGF/FGFR Signaling in Disease Pathogenesis
inferred← citeshttps://doi.org/10.6084/m9.figshare.26720673openalex-snapshot
Additional file 1 of The diverse dependence of galectin-1 and -8 on multivalency for the modulation of FGFR1 endocytosis
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.